U.S. Markets closed

Amicus Therapeutics, Inc. – Value Analysis (NASDAQ:FOLD) : November 7, 2017

CapitalCube
Capital Cube
Amicus Therapeutics, Inc. – Value Analysis (NASDAQ:FOLD) : November 7, 2017

Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Amicus Therapeutics, Inc. a score of 19. Our analysis is based on comparing Amicus Therapeutics, Inc. with the following peers – Protalix Biotherapeutics, Inc., Biogen Inc., BioMarin Pharmaceutical Inc., Esperion Therapeutics, Inc., GlaxoSmithKline plc Sponsored ADR, Shire PLC Sponsored ADR, Novo Nordisk A/S Sponsored ADR Class B ... Read more (Read more...)